J Korean Med Sci.  2020 Dec;35(46):e394. 10.3346/jkms.2020.35.e394.

Parasitological Observation in Schoolchildren with Urogenital Schistosomiasis Following Treatment with Three Different Brands of Praziquantel

• Jin Y
• Cha S
• Lee J
• Elhag MS
• Hong ST
• Lee YH

• KMID: 2509037
• DOI: http://doi.org/10.3346/jkms.2020.35.e394

Abstract

This study compared the anthelminthic effects of three different brands of praziquantel being used in Sudan against Schistosoma haematobium (S. haematobium) infection. We enrolled 1,286 schoolchildren from six primary schools and examined their urine samples for eggs of S. haematobium at the baseline survey and follow-up two weeks after administering the medication. The schoolchildren were divided into three groups based on the three brands of praziquantel (different material production), with two school children for one brand. The overall baseline prevalence of S. haematobium infection was 15.5%. Two weeks after treatment with brands A, B, and C of praziquantel, cure rates were 87.1%, 82.4% and 83.8% respectively, and the egg-reduction rates were 69.0%, 81.0% and 70.6% respectively. There was no statistically significant difference in cure rates and egg-reduction rates between the three brands. We conclude that the three different commercial brands of praziquantel used in Sudan have similar anthelminthic effects on S. haematobium.

Keyword

Schistosoma haematobium; Praziquantel; Anthelminthic Effect; Cure Rate; Egg Reduction Rate; Sudan

Reference

1. Chai JY. Praziquantel treatment in trematode and cestode infections: an update. Infect Chemother. 2013; 45(1):32–43. PMID: 24265948.

2. Gryseels B. Schistosomiasis. Infect Dis Clin North Am. 2012; 26(2):383–397. PMID: 22632645.

3. Lee Y, Song HB, Jung BK, Choe G, Choi MH. Case report of urinary schistosomiasis in a returned traveler in Korea. Korean J Parasitol. 2020; 58(1):51–55. PMID: 32145727.

4. Kabuyaya M, Chimbari MJ, Mukaratirwa S. Efficacy of praziquantel treatment regimens in pre-school and school aged children infected with schistosomiasis in sub-Saharan Africa: a systematic review. Infect Dis Poverty. 2018; 7(1):73. PMID: 29986763.

5. Zwang J, Olliaro P. Efficacy and safety of praziquantel 40 mg/kg in preschool-aged and school-aged children: a meta-analysis. Parasit Vectors. 2017; 10(1):47. PMID: 28126024.

6. World Health Organization. What is schistosomiasis? Accessed July 17, 2020. https://www.who.int/schistosomiasis/disease/en.

7. Wang XY, He J, Juma S, Kabole F, Guo JG, Dai JR, et al. Efficacy of China-made praziquantel for treatment of Schistosomiasis haematobium in Africa: a randomized controlled trial. PLoS Negl Trop Dis. 2019; 13(4):e0007238. PMID: 30969960.

8. Metwally A, Bennett J, Botros S, Ebeid F, el attar GD. Impact of drug dosage and brand on bioavailability and efficacy of praziquantel. Pharmacol Res. 1995; 31(1):53–59. PMID: 7784306.

9. Lee YH, Jeong HG, Kong WH, Lee SH, Cho HI, Nam HS, et al. Reduction of urogenital schistosomiasis with an integrated control project in Sudan. PLoS Negl Trop Dis. 2015; 9(1):e3423. PMID: 25569278.

10. Cha S, Elhag MS, Lee YH, Cho DS, Ismail HA, Hong ST. Epidemiological findings and policy implications from the nationwide schistosomiasis and intestinal helminthiasis survey in Sudan. Parasit Vectors. 2019; 12(1):429. PMID: 31488219.

11. MERCK. 2019 Annual report. Updated 2019. Accessed August 28, 2020. https://www.merckgroup.com/en/annualreport/2019/downloads/merck_annual_report_2019.pdf.

12. Saathoff E, Olsen A, Magnussen P, Kvalsvig JD, Becker W, Appleton CC. Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa. BMC Infect Dis. 2004; 4:40. PMID: 15471549.

13. Kabuyaya M, Chimbari MJ, Manyangadze T, Mukaratirwa S. Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa. Infect Dis Poverty. 2017; 6(1):83. PMID: 28385154.

14. Kimani BW, Mbugua AK, Kihara JH, Ng'ang'a M, Njomo DW. Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya. PLoS Negl Trop Dis. 2018; 12(10):e0006852. PMID: 30332403.

15. Weber MC, Blair DM, Clarke VV. The significance of schistosome eggs in the urine after treatment. Cent Afr J Med. 1969; 15(4):82–85. PMID: 5816353.